Haynes Robinson
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Haynes Robinson.
Human Mutation | 2008
Dustin Baldridge; Ulrike Schwarze; Roy Morello; Jennifer Lennington; Terry Bertin; James M. Pace; Melanie Pepin; MaryAnn Weis; David R. Eyre; Jennifer Walsh; Deborah M Lambert; Andrew Green; Haynes Robinson; Melonie Michelson; Gunnar Houge; Carl Lindman; Judith Martin; Jewell C. Ward; Emmanuelle Lemyre; John J. Mitchell; Deborah Krakow; David L. Rimoin; Daniel H. Cohn; Peter H. Byers; Brendan Lee
Autosomal dominant osteogenesis imperfecta (OI) is caused by mutations in the genes (COL1A1 or COL1A2) encoding the chains of type I collagen. Recently, dysregulation of hydroxylation of a single proline residue at position 986 of both the triple‐helical domains of type I collagen α1(I) and type II collagen α1(II) chains has been implicated in the pathogenesis of recessive forms of OI. Two proteins, cartilage‐associated protein (CRTAP) and prolyl‐3‐hydroxylase‐1 (P3H1, encoded by the LEPRE1 gene) form a complex that performs the hydroxylation and brings the prolyl cis‐trans isomerase cyclophilin‐B (CYPB) to the unfolded collagen. In our screen of 78 subjects diagnosed with OI type II or III, we identified three probands with mutations in CRTAP and 16 with mutations in LEPRE1. The latter group includes a mutation in patients from the Irish Traveller population, a genetically isolated community with increased incidence of OI. The clinical features resulting from CRTAP or LEPRE1 loss of function mutations were difficult to distinguish at birth. Infants in both groups had multiple fractures, decreased bone modeling (affecting especially the femurs), and extremely low bone mineral density. Interestingly, “popcorn” epiphyses may reflect underlying cartilaginous and bone dysplasia in this form of OI. These results expand the range of CRTAP/LEPRE1 mutations that result in recessive OI and emphasize the importance of distinguishing recurrence of severe OI of recessive inheritance from those that result from parental germline mosaicism for COL1A1 or COL1A2 mutations. Hum Mutat 0, 1–8, 2008.
Pediatric and Developmental Pathology | 1998
Bahig M. Shehata; Kathleen Patterson; Jean Thomas; Diane Scala-Barnett; Sarada Dasu; Haynes Robinson
ABSTRACT Histiocytoid cardiomyopathy (HC), a rare arrhythmogenic disorder, presents as difficult-to-control arrhythmias or sudden death in infants and children, particularly girls. Three cases are described with autopsy findings. In two cases, yellow-tan nodules were grossly visible in the myocardium; in the third case, no gross lesions were identified. Microscopic examination in all three cases revealed multiple, scattered clusters of histiocytoid myocytes which on ultrastructural examination were filled with abnormal mitochondria, scattered lipid droplets, and scanty myofibrils. These pathologic findings are similar to those previously described. The pathogenesis of this entity remains controversial. It was recently proposed that this disorder is X-linked dominant with the associated gene located in the region of Xp22.
Advances in Anatomic Pathology | 2008
Bahig M. Shehata; Christina Stockwell; Amilcar A. Castellano-Sanchez; Shannon Setzer; Christine L. Schmotzer; Haynes Robinson
von Hippel-Lindau (VHL) disease is an inherited multisystem familial cancer syndrome caused by mutations of the VHL gene on chromosome 3p25. A wide variety of neoplastic processes are known to be associated with VHL disease. The consequences of the VHL mutations and the pathway for tumor development continue to be elucidated. This paper will detail the variety of tumors associated with VHL disease and discuss the genetic mechanisms that lead to the predisposition for neoplasia.
American Journal of Human Genetics | 2012
Amy E. Merrill; Anna Sarukhanov; Pavel Krejčí; Brian Idoni; Natalia Camacho; Kristine D. Estrada; Karen M. Lyons; Hannah Deixler; Haynes Robinson; David Chitayat; Cynthia J. Curry; Ralph S. Lachman; William R. Wilcox; Deborah Krakow
Fibroblast growth factor receptor 2 (FGFR2) is a crucial regulator of bone formation during embryonic development. Both gain and loss-of-function studies in mice have shown that FGFR2 maintains a critical balance between the proliferation and differentiation of osteoprogenitor cells. We have identified de novo FGFR2 mutations in a sporadically occurring perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Histological analysis of the long bones revealed that the growth plate contained smaller hypertrophic chondrocytes and a thickened hypercellular periosteum. Four unrelated affected individuals were found to be heterozygous for missense mutations that introduce a polar amino acid into the hydrophobic transmembrane domain of FGFR2. Using diseased chondrocytes and a cell-based assay, we determined that these mutations selectively reduced plasma-membrane levels of FGFR2 and markedly diminished the receptors responsiveness to extracellular FGF. All together, these clinical and molecular findings are separate from previously characterized FGFR2 disorders and represent a distinct skeletal dysplasia.
Fetal and Pediatric Pathology | 1988
Robert W. Novak; Dimitris P. Agamanolis; Sarada Dasu; Howard J. Igel; Marvin S. Platt; Haynes Robinson; Bahig Shehata
The value of histologic evaluation in the analysis of material from first trimester abortions is not completely defined. We prospectively analyzed placenta and decidua from 75 first trimester, spontaneous abortions to ascertain if morphologic features were predictive of karyotype. The histologic features analyzed included hydropic villus change, villus fibrosis, villus scalloping with trophoblastic invaginations, atypical stromal cells, aggregates of lymphocytes in placenta or decidua, and acute inflammation of placenta or decidua. Normal karyotypes were observed in 44 cases and abnormal karyotypes were demonstrated in 31. The presence of villus scalloping with trophoblastic invagination was significantly associated with abnormal karyotypes, particularly triploidy, and the demonstration of acute inflammation was seen significantly more often in cases with normal karyotypes. We conclude that histology can provide only a suggestion as to the likelihood of an abnormal karyotype; the findings are not specific enough to obviate the need for karyotyping in the individual case.
American Journal of Medical Genetics Part A | 2014
Susan A. Woods; Haynes Robinson; Lisa J. Kohler; Dimitris P. Agamanolis; George Sterbenz; Mohamed Khalifa
Rubinstein–Taybi syndrome (RTS) and Cornelia de Lange syndrome (CdLS) are genetically heterogeneous multiple anomalies syndromes, each having a distinctive facial gestalt. Two genes (CREBBP and EP300) are known to cause RTS, and five (NIPBL, SMC1A, SMC3, RAD21, and HDAC8) have been associated with CdLS. A diagnosis of RTS or CdLS is molecularly confirmed in only 65% of clinically identified cases, suggesting that additional causative genes exist for both conditions. In addition, although EP300 and CREBBP encode homologous proteins and perform similar functions, only eight EP300 positive RTS patients have been reported, suggesting that patients with EP300 mutations might be escaping clinical recognition. We report on a child with multiple congenital abnormalities and intellectual disability whose facial features and complex phenotype resemble CdLS. However, no mutations in CdLS‐related genes were identified. Rather, a novel EP300 mutation was found on whole exome sequencing. Possible links between EP300 and genes causing CdLS are evident in the literature. Both EP300 and HDAC8 are involved in the regulation of TP53 transcriptional activity. In addition, p300 and other chromatin associated proteins, including NIPBL, SMCA1, and SMC3, have been found at enhancer regions in different cell types. It is therefore possible that EP300 and CdLS‐related genes are involved in additional shared pathways, producing overlapping phenotypes. As whole exome sequencing becomes more widely utilized, the diverse phenotypes associated with EP300 mutations should be better understood. In the meantime, testing for EP300 mutations in those with features of CdLS may be warranted.
Neurology | 1986
Dimitris P. Agamanolis; Joseph L. Potter; Herbert K. Naito; Haynes Robinson; Thiruvengadam Kulasekaran
Two siblings had olivopontocerebellar degeneration, failure to thrive, hepatic fatty change and cirrhosis, and a dyslipoproteinemia characterized by low cholesterol and elevated triglycerides. This condition was distinct from other cerebellar atrophies and ataxias and was not due to malabsorption or malnutrition. Cerebellar degeneration progressed rapidly during the first year of life, and both children died from intercurrent infections and surgical complications at 11 and 17 months. Stereotyped clinical and pathologic findings in the two patients suggest a previously unreported genetic metabolic disorder affecting the liver and the CNS.
Fetal and Pediatric Pathology | 2010
Wendy L. Coto-Puckett; Enid Gilbert-Barness; Charlotte K. Steelman; Tami Stuart; Haynes Robinson; Bahig M. Shehata
Neu-Laxova syndrome is a rare autosomal recessive disorder characterized by severe intra-uterine growth restriction, extreme microcephaly, marked edema with skin restriction, ichthyosis, craniofacial anomalies, limb deformities, and a spectrum of central nervous system malformations. Less than 70 cases have been described since the first report in 1971. To this day the etiology and genetic basis remains unknown. Consanguinity has been reported. Some authors have postulated the syndrome to be a form of neuro-ectodermal dysplasia, while others suggest that it is a malformation syndrome secondary to severe skin restriction. Although the outcome of this syndrome is lethal, a single case of longer survival (6 months) has been reported. The majority of cases are stillborn or die shortly after birth. Thus, it is clear that Neu-Laxova exhibits a spectrum of disease, with varying degrees of phenotypic expression. We are presenting three new cases of Neu-Laxova syndrome; two were stillbirths and one lived for eleven weeks. Our microscopic and post-mortem findings in these three cases display the vast spectrum of this rare syndrome
Obstetrics & Gynecology | 2002
William M. Curtin; Bahig Shehata; Sadik A. Khuder; Haynes Robinson; Brian C. Brost
OBJECTIVE To determine the feasibility of using calculated nucleated red blood cell (RBC) counts from histologic placental slides to predict newborn nucleated RBC counts. METHODS This retrospective study compared absolute nucleated RBC counts from 24 newborns, diagnosed with fetal distress in labor, with counts calculated from their histologic placental slides. A simple linear regression model was tested with newborn nucleated RBC counts as the dependent variable and calculated placental nucleated RBC counts as the independent variable. RESULTS The mean ± standard deviation newborn nucleated RBC count was 4.81 × 109 ± 5.46 × 109/L compared with 1.37 × 109 ± 1.78 × 109/L calculated from placental sections. These data were normalized by logarithmic transformation. A significant linear regression was obtained, r2 = 0.74, P < .001. The prediction equation obtained was natural logarithm (newborn nucleated RBC count) is equal to 1.002 × natural logarithm (placental nucleated RBC count) + 1.173. CONCLUSION It is feasible to calculate nucleated RBC counts from histologic slides of the placenta that are predictive of newborn nucleated RBC counts. Further work on more homogeneous groups of subjects is necessary to increase the precision of the method. The placenta could serve as a surrogate source for newborn whole blood nucleated RBC counts around the time of birth.
American Journal of Medical Genetics Part A | 2005
Anne Slavotinek; Haynes Robinson; M.A. Steele
Fryns syndrome (FS) comprises congenital diaphragmatic hernia (CDH) and pulmonary hypoplasia, craniofacial dysmorphism, brachytelephalangy with nail hypoplasia, orofacial clefting, and organ malformations including cerebellar and neuronal heterotopias, renal cysts, and bicornuate uteri [Fitch etal., 1978;Frynsetal., 1979;Lubinskyetal., 1983;Pinaretal., 1994; Slavotinek, 2004]. The inheritance is autosomal recessive. Although brachytelephalangy and hypoplasia of the distal phalanges are well-recognized skeletal findings in FS, we report a child with osteochondrodysplasia and FS, the second report of this association after the original description of osteochondrodysplasia in two siblings with FS [Kershisnik et al., 1991]. The baby was the first child born to a 31-year-old primigravida. Prenatal ultrasound scans showed a large cystic hygroma and anasarca and the amniotic AFP level was elevated at 1.98 multiples of mean. Labor was induced at 24weeks of gestation and a stillborn female babywas delivered (Fig. 1). Measurements were large for gestational age with a birthweight of 1,267 g (expectedweight 630 g) and crown rump length of 24 cm (expected 20.8 cm). The baby had severe hydropswitha large cystic hygromaandpleural andperitoneal effusions. There was bilateral CDH with pulmonary hypoplasia andhypoplasia of the distal digitswith small nails although the distal phalanges were obscured by edema. The baby had a unilateral right cleft of the soft palate, a bifid epiglottis, tetralogy of Fallot, a persistent left superior vena cava and